Market By Product, Application, End-user And Geography | Forecast 2019-2027
According to a study by Triton, the western blotting market in North America is anticipated to rise with a CAGR of 3.80% throughout the estimated years from 2019-2027.
The countries that have been scrutinized in North America’s western blotting market are:
• The United States
• Canada
The market for western blotting in North America is projected to flourish as the adoption of western blot technology is expected to rise during the forecast period of 2019-2027. The rising rate of chronic diseases such as hepatitis, HIV/AIDS and herpes simplex virus in conjunction, coupled with the increasing number of research & development activities by pharmaceutical and biotechnological companies, is expected to drive the growth of this market. Moreover, the presence of the region’s topmost market players who undertake strategic initiatives, such as new product developments and mergers & acquisitions, is expected to make this region a rewarding segment by signaling enormous growth opportunities.
Report scope can be customized per your requirements. Request For Customization
In addition, the R&D centers of biotechnology and pharmaceutical companies are located in North America because of the availability of advanced technology and the presence of expert personnel and have been continuously engaged in the development of HIV and AIDS vaccinations. Also, the region is conducting many research activities, including scientific & medical research to find optimum solutions in various sectors. For instance, research in agriculture and biotechnology has increased the usage of genetically modified crops for high yield, insect resistance, and faster growth. Furthermore, the American region is receiving significant funding from the National Institutes of Health (NIH) to carry out research activities in the field of biotechnology, focusing on areas such as biotechnology and human health. These factors will boost the demand for western blotting products across the Americas during the forecast period. The regional market has gained dominance owing to the presence of government organizations such as the CDC. Furthermore, increasing the production of genetically modified crops in the US, the collaborative program between the US and China for biomedical research and the rise in research funding and are expected to propel the western blotting market.
Bio-Rad Laboratories, Inc., is a US-based life science research and medical device company. The company has its operations across the US, Canada, Latin America, Europe and the Pacific Rim. Bio-Rad Laboratories reported revenues of US $2,160.2 million for FY2017, with an increase of 4.4% over FY2016. The increasing regulatory approvals by the authorities, coupled with increasing healthcare spending in the U.S., are expected to boost the growth of the company.
1.
NORTH AMERICA WESTERN BLOTTING MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. GROWING NUMBER OF APPLICATIONS FOR WESTERN
BLOTTING
2.2.2. GROWING ACCEPTANCE OF DIGITAL WESTERN
BLOTTING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWING OCCURRENCE OF HIV AND LYME DISEASE
2.6.2. HIGH DEMAND FOR PROTEOMICS
2.6.3. RISE IN APPLICATIONS FOR WESTERN BLOTTING
2.7. MARKET RESTRAINTS
2.7.1. ADVANCEMENTS IN SUBSTITUTE TECHNOLOGIES
2.8. MARKET OPPORTUNITIES
2.8.1. INDUSTRIALIZATION OF WESTERN BLOT INSTRUMENTS
2.9. MARKET CHALLENGES
2.9.1. INFLATED COST OF ANTIBODIES
2.9.2. GROWING RESEARCH INITIATIVES AND R&D
EXPENDITURE BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
3.
WESTERN BLOTTING MARKET OUTLOOK - BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS AND BUFFERS
3.1.2. KITS
3.1.3. OTHER CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING SYSTEMS
3.2.2.1. DRY BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY BLOTTING SYSTEMS
3.2.2.3. WET BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT IMAGERS
3.2.3.2. FLUORESCENT IMAGERS
3.2.3.3. OTHER IMAGERS
4.
WESTERN BLOTTING MARKET OUTLOOK - BY APPLICATION
4.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
4.2. DISEASE DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER APPLICATIONS
5.
WESTERN BLOTTING MARKET OUTLOOK - BY END-USER
5.1. RESEARCH INSTITUTES
5.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC CENTERS
5.4. OTHER END-USERS
6.
WESTERN BLOTTING MARKET - REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
7.
COMPETITIVE LANDSCAPE
7.1. F. HOFFMAN LA-ROCHE LTD.
7.2. MERCK KGAA
7.3. THERMO FISHER SCIENTIFIC INC.
7.4. BIO-RAD TECHNOLOGIES INC.
7.5. BIO-TECHNE CORPORATION
7.6. CELL SIGNALING TECHNOLOGY INC.
7.7. GE HEALTHCARE
7.8. LI-COR INC.
7.9. ADVANSTA
7.10. AZURE BIOSYSTEMS INC.
7.11. PERKINELEMER INC.
7.12. ROCHE DIAGNOSTICS INTERNATIONAL INC.
7.13. ROCHE DIAGNOSTICS
7.14. LUMIGEN INC.
7.15. ROCKLAND IMMUNOCHEMICALS INC.
8.
METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1. NORTH AMERICA WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027
(IN $ MILLION)
TABLE 2. MARKET ATTRACTIVENESS INDEX
TABLE 3. VENDOR SCORECARD
TABLE 4. NORTH AMERICA WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027
(IN $ MILLION)
TABLE 5. NORTH AMERICA WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2027
(IN $ MILLION)
TABLE 6. NORTH AMERICA WESTERN BLOTTING MARKET, BY APPLICATION,
2019-2027 (IN $ MILLION)
TABLE 7. NORTH AMERICA WESTERN BLOTTING MARKET, BY END-USER, 2019-2027
(IN $ MILLION)
FIGURE 1. PORTER’S FIVE FORCE ANALYSIS
FIGURE 2. NORTH AMERICA WESTERN BLOTTING MARKET, BY CONSUMABLES,
2019-2027 (IN $ MILLION)
FIGURE 3. NORTH AMERICA WESTERN BLOTTING MARKET, BY REAGENTS AND
BUFFERS, 2019-2027 (IN $ MILLION)
FIGURE 4. NORTH AMERICA WESTERN BLOTTING MARKET, BY KITS, 2019-2027 (IN
$ MILLION)
FIGURE 5. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES,
2019-2027 (IN $ MILLION)
FIGURE 6. NORTH AMERICA WESTERN BLOTTING MARKET, BY INSTRUMENTS,
2019-2027 (IN $ MILLION)
FIGURE 7. NORTH AMERICA WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS
INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8. NORTH AMERICA WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS,
2019-2027 (IN $ MILLION)
FIGURE 9. NORTH AMERICA WESTERN BLOTTING MARKET, BY DRY BLOTTING
SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 10. NORTH AMERICA WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING
SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 11. NORTH AMERICA WESTERN BLOTTING MARKET, BY WET BLOTTING
SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 12. NORTH AMERICA WESTERN BLOTTING MARKET, BY IMAGERS, 2019-2027
(IN $ MILLION)
FIGURE 13. NORTH AMERICA WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT
IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 14. NORTH AMERICA WESTERN BLOTTING MARKET, BY FLUORESCENT
IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 15. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER IMAGERS,
2019-2027 (IN $ MILLION)
FIGURE 16. NORTH AMERICA WESTERN BLOTTING MARKET, BY BIOMEDICAL &
BIOCHEMICAL RESEARCH, 2019-2027 (IN $ MILLION)
FIGURE 17. NORTH AMERICA WESTERN BLOTTING MARKET, BY DISEASE
DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 18. NORTH AMERICA WESTERN BLOTTING MARKET, BY AGRICULTURE,
2019-2027 (IN $ MILLION)
FIGURE 19. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS,
2019-2027 (IN $ MILLION)
FIGURE 20. NORTH AMERICA WESTERN BLOTTING MARKET, BY RESEARCH
INSTITUTES, 2019-2027 (IN $ MILLION)
FIGURE 21. NORTH AMERICA WESTERN BLOTTING MARKET, BY PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES, 2019-2027 (IN $ MILLION)
FIGURE 22. NORTH AMERICA WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS,
2019-2027 (IN $ MILLION)
FIGURE 23. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER END-USERS,
2019-2027 (IN $ MILLION)
FIGURE 24. NORTH AMERICA WESTERN BLOTTING MARKET, REGIONAL OUTLOOK, 2018
& 2027 (IN %)
FIGURE 25. UNITED STATES WESTERN BLOTTING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 26. CANADA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)